Talita Mota Gonçalves

Talita Mota Gonçalves

Auto-generated profile, based on publicly available information

Talita Mota Gonçalves

Universidade Federal de Pernambuco

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Journal of Chromatography B
Verified
Journal Article
Closed access
DBD.C.G. Bedor
D.C.G. Bedor
TGT.M. Gonçalves
T.M. Gonçalves
MFM.L.L. Ferreira
M.L.L. Ferreira
CSC.E.M. de Sousa
C.E.M. de Sousa
AMA.L. Menezes
A.L. Menezes
DSD.P. de Santana
D.P. de Santana

30 November 2010 in Clinical Therapeutics
Verified
Journal Article
Closed access
PDF file
JFJosé Homero de Souza Filho
José Homero de Souza Filho
FBFelipe Nunes Bonifácio
Felipe Nunes Bonifácio
DBDanilo César Galindo Bedor
Danilo César Galindo Bedor
VRVirna Ligiane Ramos
Virna Ligiane Ramos
CSCarlos Eduardo Miranda de Sousa
Carlos Eduardo Miranda de Sousa
DSDavi Pereira de Santana
Davi Pereira de Santana

1 August 2013 in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Verified
Journal Article
Closed access
TGTalita Mota Goncalves
Talita Mota Goncalves
KAKamel Alhanout
Kamel Alhanout
ANAlain Nicolay
Alain Nicolay
JDJean-Christophe Dubus
Jean-Christophe Dubus
DSDavi Pereira de Santana
Davi Pereira de Santana
VAVeronique Andrieu
Veronique Andrieu
Background: The use of valved holding chambers (VHCs) with pressurized metered dose inhalers (pMDIs) is reported to reduce the oral deposition of inhaled drugs and to facilitate the handling of these devices by patients, especially children. Although the number of commercially available VHCs is increasing, the correct choice of VHC in clinical practice is important, because VHCs are not equally effective regarding medication delivery. Hence, we aimed to evaluate the use of three small-volume VHCs—Vortex®, AeroChamber® Plus (ACP), and Able Spacer™ (AS)—along with a commercial pMDI containing a combination of beclomethasone and formoterol (Innovair®) frequently used by asthma patients. Methods: Evaluation of the delivered dose of both drugs and analysis of particle size distribution of aerosols emitted for the inhaler were performed using the Next Generation Impactor with and without the tested VHCs. Results: The VHCs retained significant quantities of both drugs and dramatically reduced the quantity of drugs deposited in the throat of the impactor, indicating that particles with large size were preferably retained in the VHCs. Interestingly, although the delivered dose of both drugs was reduced by the use of VHCs, the use of the Vortex and the ACP resulted in comparable fine particle doses (FPDs) to that obtained when the pMDI was used alone, whereas the AS VHC significantly reduced the FPDs of both drugs. This may be due to the fact that, unlike the AS VHC, the Vortex and the ACP VHCs are made of antistatic materials that minimize the electrostatic interaction with emitted aerosols, enhancing medication delivery. Conclusion: The Vortex and the ACP VHCs present interesting advantages over the AS VHC to be used with Innovair pMDI. However, these results are based on an in vitro evaluation and need to be validated in an in vivo study in order to clinically assess the performance of these VHCs.

19 March 2021 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
YMYugo Araújo Martins
Yugo Araújo Martins
TGTalita Mota Gonçalves
Talita Mota Gonçalves
Renata Fonseca Vianna  LopezRenata Fonseca Vianna Lopez
Renata Fonseca Vianna Lopez

1 January 2011 in Química Nova
Verified
Journal Article
Open access
PDF file
DBDanilo Cesar Galindo Bedor
Danilo Cesar Galindo Bedor
JFJose Homero de Souza Filho
Jose Homero de Souza Filho
VRVirna Ligiane Souza Ramos
Virna Ligiane Souza Ramos
TGTalita Mota Gonçalves
Talita Mota Gonçalves
CSCarlos Eduardo Miranda de Sousa
Carlos Eduardo Miranda de Sousa
DSDavi Pereira de Santana
Davi Pereira de Santana
An LC-MS/MS method has been developed for the determination of efavirenz (EFZ) in human plasma using hydrochlorothiazide as internal standard (I.S.). An ESI negative mode with multiple reaction-monitoring was used monitoring the transitions m/z 313.88→69.24 (EFZ) and 296.02→204.76 (I.S.). Samples were extracted using liquid-liquid extraction. The total run time was 2.0 min. The separation was achieved with HPLC-RP using a monolithic column. The assay was linear in the concentration range of 100 - 5000 ng mL-1. The mean recovery was 83%. Intra- and inter-day precision were < 9.5% and < 8.9%, respectively and accuracy was in the range ± 8.33%. The method was successfully applied to a bioequivalence study

1 February 2008 in Arzneimittelforschung
Verified
Journal Article
Closed access
PDF file
TGTalita Mota Gonçalves
Talita Mota Gonçalves
DBDanilo César Galindo Bedor
Danilo César Galindo Bedor
LALuís Abreu
Luís Abreu
CSCarlos Sousa
Carlos Sousa
CRClarice Madalena Bueno Rolim
Clarice Madalena Bueno Rolim
DSDavi Santana
Davi Santana
A simple, fast, sensitive and selective solid-phase extraction-liquid chromatography-tandem mass spectrometry (SPE-LC-MS/MS) method for the quantitative analysis of ampicillin (CAS 69-53-4) in human plasma was developed using amoxicillin as internal standard, and sample extraction by solid-phase extraction (SPE). Extracts were separated by reversed-phase C18 with aqueous mobile phase (acetonitrile, 80:20, v/v) with 0.1% formic acid. The method was validated and successfully applied in a bioequivalence study of capsules 500 mg of ampicillin. Using a short running time of 2.5 min, the lower limit of quantification (LLOQ) for obtained ampicillin was 0.1 µg/ml for a plasma sample of 250 µl and a recovery of 94.38% ± 4.05. Bioequivalence between the products was determined by calculating 90% confidence intervals (CI) for the ratio of Cmax, AUC0–t and AUC0–inf values for the test and reference products, which were within the 0.80–1.25 interval proposed by FDA and EMEA. It is concluded that the two formulations are bioequivalent in their rate and extent of absorption, and thus, may be used interchangeably.